EP 1224303 A2 20020724 - TMS1 COMPOSITIONS AND METHODS OF USE
Title (en)
TMS1 COMPOSITIONS AND METHODS OF USE
Title (de)
TMS1 ZUSAMMENSETZUNGEN UND METHODEN ZUR VERWENDUNG
Title (fr)
COMPOSITIONS DU GENE TMS1 ET PROCEDES D'UTILISATION
Publication
Application
Priority
- US 0028747 W 20001018
- US 15997599 P 19991018
Abstract (en)
[origin: WO0129235A2] The invention relates to the identification of a novel gene, TMS1, which is transcriptionally silenced as a result of methylation. Nucleic acids and polypeptides are provided as are methods and tools for diagnosing and treating disorders characterized by such methylation, and/or abnormally low levels of TMS1 expression products.
IPC 1-7
IPC 8 full level
C07K 14/47 (2006.01); C12Q 1/68 (2006.01); C12Q 1/6886 (2018.01); A61K 38/00 (2006.01)
CPC (source: EP)
C07K 14/47 (2013.01); C12Q 1/6886 (2013.01); A61K 38/00 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/154 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01)
Citation (search report)
See references of WO 0129235A2
Citation (examination)
- [online] 16 August 2000 (2000-08-16), CONWAY K.E. ET AL: "Homo sapiens target of methylation-induced silencing-1 (TMS1) mRNA, complete cds, alternatively spliced.", retrieved from EMBL Database accession no. AF255794
- DATABASE EMBL [online] 22 August 2000 (2000-08-22), CONWAY K.E. ET AL: "Homo sapiens target of methylation-induced silencing 1 (TMS1) mRNA, complete cds.", Database accession no. AF184073
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0129235 A2 20010426; WO 0129235 A3 20020516; AU 1211001 A 20010430; AU 785115 B2 20060921; CA 2386476 A1 20010426; EP 1224303 A2 20020724
DOCDB simple family (application)
US 0028747 W 20001018; AU 1211001 A 20001018; CA 2386476 A 20001018; EP 00973614 A 20001018